I would be remiss if I failed to note that, earlier this summer, parents of children who suffer from allergies were suddenly faced with dramatic increases for epinephrine injectors or Epipens.

You indicated in your testimony and in part in response to my questions that often substance within the application process, substance within that application is insufficient for an approval.

I think this is a subject area where if it is not the number one issue, that is why a lot of folks that I represent feel ruled and not governed, and they get really upset.

I hope our focus in this hearing will continue to be how do we make certain that FDA is doing its job well.

Can you report anything about the status of those negotiations, or is that beyond your----

It seems to me that the law should be compatible with what is right and wrong.

the fact that Iran uses its capabilities, its financial capabilities to fund terrorists, as you say, is known.

It has significant consequences to Kansas families.

Let me say, with regards to those proposed cuts not in this room, not on my watch, not on the watch of many of us here on the Committee.

But it seems to me we have missed a tremendous opportunity to satisfy the claims of American citizens against the Iranian Government that are legitimate and have gone to judgment.

This Committee passed the first forestry bill in 13 years that gets into management reform.

I think we are about to wrap up our hearing, assuming I do not talk so long that other members and other Senators arrive.

The FDA's role in the drug approval process is critical to expanding the pharmaceutical market and driving down costs for consumers.

Is there a timeframe in which you would expect that consequences to Congress to occur?

I also mentioned that you were able--I know this is not a generic drug, but we were talking about Duchenne and the muscular dystrophy drug.

today I would like to honor the life of police captain Dave Melton, a law enforcement officer who served 17 years on the force of the Kansas City Police Department and was tragically killed on duty earlier this summer. On Tuesday, July 19…

In my view, this hearing was what a congressional hearing in most instances should be, an opportunity to be educated and to learn.

Is there a common denominator for drug companies who are required to submit additional information during the approval process?